Reflection on the governance of clinical stem cell research and applications in China.

Abstract

Regenerative MedicineVol. 12, No. 6 CommentaryReflection on the governance of clinical stem cell research and applications in ChinaHaidan ChenHaidan Chen*Author for correspondence: E-mail Address: haidan.chen@hotmail.com College of Humanities & Development Studies, China Agricultural University, 17 East Tsinghua Road, Beijing 100083, ChinaSearch for more papers by this authorPublished Online:4 Oct 2017https://doi.org/10.2217/rme-2017-0053AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: Chinaclinical stem cell researchgovernanceinstitutional logicReferences1 Zhou Q. An overview of stem cell and regenerative medicine in China and at Chinese Academy of Sciences. Chinese Bull. Life Sci. 28(8), 833–838 (2016).Google Scholar2 Lau D, Ogbogu U, Taylor B, Stafinski T, Menon D, Caulfield T. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell 3(6), 591–594 (2008).Crossref, Medline, CAS, Google Scholar3 Sipp D. The rocky road to regulation. Nature Reports Stem Cells doi:10.1038/stemcells.2009.125 (2009) (Epub ahead of print).Crossref, Google Scholar4 Song P. The proliferation of stem cell therapies in post-Mao China: problematizing ethical regulation. New Genet. Soc. 30(2), 141–153 (2011).Crossref, Google Scholar5 Chen H, Gottweis H. Stem cell treatments in China: rethinking the patient role in the global bio-economy. Bioethics 27(4), 194–207 (2013).Crossref, Medline, Google Scholar6 Chen H. Stem cell governance in China: from bench to bedside? New Genet. Soc. 28(3), 267–282 (2009).Crossref, CAS, Google Scholar7 Zhang JY. The Cosmopolitanization of Science: Stem Cell Governance in China. Palgrave MacMillan, Basingstoke & NY, UK & USA (2012).Crossref, Google Scholar8 Rosemann A. Medical innovation and national experimental pluralism: insights from clinical stem cell research and applications in China. Biosocieties 8(1), 58–74 (2013).Crossref, Google Scholar9 Sui S, Sleeboom-Faulkner M. Governance of stem cell research and its clinical translation in China. East Asian Sci. Technol. Soc. (9), 1–16 (2015).Google Scholar10 Sleeboom-Faulkner M, Chen H, Rosemann A. Regulatory capacity building and the governance of clinical stem cell research in China. Science and Public Policy (2017) (Forthcoming).Medline, Google Scholar11 Zhou X. Centralization of authority and effective governance: the institutional logic of governance in contemporary China. Open Times (10), 67–85 (2011).Google Scholar12 Zhou X. The Institutional Logic of Governance in China: An Organizational Approach. SDX-Joint Publishing Company, Beijing, China (2017).Google Scholar13 Zhou X. Mobilization mode of governance: rethinking the institutional logic of governance in China. Open Times (9), 105–125 (2012).Google Scholar14 MoH. [The Notification on self-evaluation and self-correction work regarding the development of clinical stem cell research and applications] (2011). www.moh.gov.cn/zwgkzt/pkjjy1/201201/53890.shtml.Google Scholar15 Cyranoski D. China's stem-cell rules go unheeded. Nature 484(7393), 149–150 (2012).Crossref, Medline, CAS, Google Scholar16 MoH and SFDA. Regulation for stem cell clinical trials (Trial) and interrelated draft regulations for public comments (2013). www.sda.gov.cn/WS01/CL1037/78934.html.Google Scholar17 NHFPC and CFDA. Regulation for clinical stem cell research (Trial) (2015). www.sda.gov.cn/WS01/CL0053/127243.html.Google Scholar18 NHFPC. The publicity of the first batch of clinical stem cell research institutions to put on record (2016). www.nhfpc.gov.cn/qjjys/s7946/201605/b73fb21230ec400ebbc57d726a1d0d69.shtml.Google Scholar19 The Logistics Department of Military Commission. The publicity of the first batch of military hospitals’ clinical stem cell research institutions to put on record (2017). www.81.cn/jwgz/2017-01/12/content_7449139.htm.Google Scholar20 Rosemann A, Bortz G, Vasen F, Sleeboom-Faulkner M. Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations. Regen. Med. 11(7), 647–657 (2016).Link, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByApplication of artificial intelligence in glioma researches: A bibliometric analysis11 August 2022 | Frontiers in Oncology, Vol. 12Strengthening regulations, recent advances and remaining barriers in stem cell clinical translation in China: 2015–2021 in reviewPharmacological Research, Vol. 182Creative regulatory practices to develop stem-cell technology: the way forward for MalaysiaMohammad Firdaus Bin Abdul Aziz, Michael Morrison & Jane Kaye15 December 2021 | Regenerative Medicine, Vol. 17, No. 2Stem Cell Translational Medicine: The Tianjin Model Revisited1 November 2021 | Stem Cells Translational Medicine, Vol. 10, No. S2Research trends of stem cells in ischemic stroke from 1999 to 2018: A bibliometric analysisClinical Neurology and Neurosurgery, Vol. 192The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis8 August 2019 | International Journal of Molecular Sciences, Vol. 20, No. 16Multipotent Mesenchymal Stromal Cells for Pulmonary Fibrosis?The American Journal of the Medical Sciences, Vol. 357, No. 5Global Diversification in Medicine Regulation: Insights from Regenerative Stem Cell Medicine20 December 2018 | Science as Culture, Vol. 28, No. 2Research on Visualization of Domestic Architecture Management Information System Based on Knowledge Atlas5 November 2018 | IOP Conference Series: Materials Science and Engineering, Vol. 439Special focus issue on regenerative medicine in society: interdisciplinary perspectives (part I) – ForewordAchim Rosemann, Jan Barfoot & Clare Blackburn11 October 2017 | Regenerative Medicine, Vol. 12, No. 6 Vol. 12, No. 6 Follow us on social media for the latest updates Metrics Downloaded 110 times History Published online 4 October 2017 Published in print September 2017 Information© 2017 Future Medicine LtdKeywordsChinaclinical stem cell researchgovernanceinstitutional logicAcknowledgementsI thank Xueguang Zhou for his comments on an early version of this article.Financial & competing interests disclosureThe research for this article was supported by the National Social Sciences Foundation of China (Grant No: 15BZX035). The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download